Journal Article Research Support, Non-U.S. Gov't Epublish 37 citations
PubMed: 34880831 DOI: 10.3389/fendo.2021.739228
Ovarian Endometrioma Negatively Impacts Oocyte Quality and Quantity But Not Pregnancy Outcomes in Women Undergoing IVF/ICSI Treatment: A Retrospective Cohort Study.
Front Endocrinol (Lausanne) 12:739228
Authors: Yaoqiu Wu, Rong Yang, Jie Lan, Haiyan Lin, Xuedan Jiao, Qingxue Zhang
Affiliations
- Reproductive Medicine Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Abstract
Purpose
To determine the impact of ovarian endometrioma on fertilization/intracytoplasmic sperm injection (IVF/ICSI) outcomes.
Methods
This retrospective study was conducted using two groups. The endometrioma group consisted of 862 women with infertility who had ovarian endometriomas and underwent their first ovarian stimulation for IVF/ICSI treatment between January 2011 to December 2019 at a public university hospital. A non-endometrioma comparison group, comprising 862 women with other infertility factors, was matched according to maternal age, body mass index (BMI), and infertility duration. Ovarian reserve and response and IVF/ICSI and pregnancy outcomes between the two groups were analyzed. Multivariate logistic regression (MLR) analysis was conducted on the basis of clinical covariates assessed for their association with live birth.
Results
The results showed that significantly lower antral follicle count (AFC), anti-Müllerian hormone (AMH), ovarian sensitivity index (OSI), oocyte maturation and fertilization rates, blastocyst rate, number of oocytes retrieved, and available embryos were found in women with endometrioma compared with the control, respectively (P < 0.05). The cumulative live birth rate patient in women with endometrioma was lower than that of women without endometrioma (39.32% . 46.87%, P = 0.002). In women with endometrioma, those who underwent surgical intervention prior to IVF/ICSI treatment had higher maturation (86.03% . 83.42%, P = 0.003), fertilization (78.16% . 74.93%, P = 0.004), and top-quality embryo rates (42.94% . 39.93%, P = 0.097) but had fewer oocytes retrieved (8.01 ± 5.70 . 9.12 ± 6.69, P = 0.013) than women without surgery. However, live birth rates were comparable between women with endometrioma and women in the control group, regardless of whether they had a prior history of ovarian surgery. MLR analysis showed no correlation between endometrioma and live birth after being adjusted for number of top-quality embryos transferred and stage of embryo transfer.
Conclusions
The data from this study supported the conclusion that ovarian endometrioma negatively impacts oocyte quality and quantity, but not overall pregnancy outcomes, in women undergoing IVF/ICSI treatment. Endometrioma lowers the cumulative live birth rate by decreasing the number of embryos. Surgical excision of endometrioma prior to IVF/ICSI can partly improve oocyte maturation and fertilization rates but not pregnancy outcomes.
MeSH
Pregnancy, Birth Rate, Parturition, Pregnancy Outcome, Ovary, Infertility, Cohort Studies, Oocytes, Therapeutics, Sperm Injections, Intracytoplasmic, Live Birth, Endocrine System Diseases, Fertilization
Cited by
- Association between follicular fluid bacteria with inflammatory markers of the complete blood count and the outcomes of assisted reproductive technology in women with endometriosis: A case-control study. Health Sci Rep, 2024
- Achieving Successful Pregnancy in a Patient With Ovarian Endometriosis Through Assisted Reproductive Technology (ART) Intervention: A Case Report. Cureus, 2024
- Development and validation of a nomogram model for predicting clinical pregnancy in endometriosis patients undergoing fresh embryo transfer. BMC Pregnancy Childbirth, 2023
- Significance of Mitochondrial Dynamics in Reproductive Physiology: Current and Emerging Horizons in Mitochondrial Therapy for Assisted Reproductive Technologies. Reprod Med Biol, 2025
- Ovarian Tissue Removed with Endometrioma May Reflect the Quality of the Adjacent Ovary. Healthcare (Basel), 2025
- Is Oocyte Quality Impaired in Cases With Ovarian Endometriosis? A Second Look Into the Clinical Setting. Front Endocrinol (Lausanne), 2022
- Single-cell dual-omics reveals translational and transcriptional landscapes and regulations in oocytes from ovarian endometriosis patients. Front Endocrinol (Lausanne), 2025
- Ovarian Stimulation for In Vitro Fertilization and Reproductive Outcome after Surgical Treatment of Endometriosis Compared with Tubal Factor Infertility. Clin Pract, 2024
- The impact of surgical intervention on time to conception and obstetric outcomes in women with endometriomas: a retrospective cohort study. BMC Pregnancy Childbirth, 2025
- The Effects of Endometriosis on Oocyte and Embryo Quality. J Clin Med, 2025